Nolato AB (publ) (ST:NOLA-B) — Market Cap & Net Worth
Market Cap & Net Worth: Nolato AB (publ) (NOLA-B)
Nolato AB (publ) (ST:NOLA-B) has a market capitalization of $1.37 Billion (Skr12.69 Billion) as of September 17, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #7581 globally and #115 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nolato AB (publ)'s stock price Skr52.50 by its total outstanding shares 241786942 (241.79 Million). Also see total assets of Nolato AB (publ) for a full breakdown of the balance sheet.
Nolato AB (publ) Market Cap History: 2015 to 2026
Nolato AB (publ)'s market capitalization history from 2015 to 2026. Data shows growth from $380.34 Million to $1.37 Billion (14.52% CAGR). Also see Nolato AB (publ) cash flow conversion for how efficiently the company converts equity into cash flow.
Nolato AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nolato AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check NOLA-B live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.17x
Nolato AB (publ)'s market cap is 0.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.07x
Nolato AB (publ)'s market cap is 2.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $406.45 Million | $4.45 Billion | $336.00 Million | 0.09x | 1.21x |
| 2017 | $864.06 Million | $6.72 Billion | $572.00 Million | 0.13x | 1.51x |
| 2018 | $598.94 Million | $8.10 Billion | $722.00 Million | 0.07x | 0.83x |
| 2019 | $924.77 Million | $7.92 Billion | $703.00 Million | 0.12x | 1.32x |
| 2020 | $1.94 Billion | $9.36 Billion | $806.00 Million | 0.21x | 2.40x |
| 2021 | $2.56 Billion | $11.61 Billion | $1.16 Billion | 0.22x | 2.21x |
| 2022 | $1.34 Billion | $10.77 Billion | $697.00 Million | 0.12x | 1.92x |
| 2023 | $1.34 Billion | $9.55 Billion | $435.00 Million | 0.14x | 3.08x |
| 2024 | $1.41 Billion | $9.66 Billion | $658.00 Million | 0.15x | 2.14x |
| 2025 | $1.61 Billion | $9.46 Billion | $777.00 Million | 0.17x | 2.07x |
Competitor Companies of NOLA-B by Market Capitalization
Companies near Nolato AB (publ) in the global market cap rankings as of September 17, 2026. Review NOLA-B tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Nolato AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Nolato AB (publ) Historical Marketcap From 2015 to 2026
Between 2015 and today, Nolato AB (publ)'s market cap moved from $380.34 Million to $ 1.37 Billion, with a yearly change of 14.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr1.37 Billion | -15.05% |
| 2025 | Skr1.61 Billion | +14.02% |
| 2024 | Skr1.41 Billion | +5.18% |
| 2023 | Skr1.34 Billion | +0.16% |
| 2022 | Skr1.34 Billion | -47.73% |
| 2021 | Skr2.56 Billion | +32.18% |
| 2020 | Skr1.94 Billion | +109.53% |
| 2019 | Skr924.77 Million | +54.40% |
| 2018 | Skr598.94 Million | -30.68% |
| 2017 | Skr864.06 Million | +112.59% |
| 2016 | Skr406.45 Million | +6.86% |
| 2015 | Skr380.34 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Nolato AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.37 Billion USD |
| MoneyControl | $1.37 Billion USD |
| MarketWatch | $1.37 Billion USD |
| marketcap.company | $1.37 Billion USD |
| Reuters | $1.37 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nolato AB (publ)
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more